AbbVie Invests $195 Million in New North Chicago API Manufacturing Site

AbbVie; North Chicago; API manufacturing; $195 million investment; facility expansion; pharmaceutical manufacturing; Illinois; domestic production

FDA Launches PreCheck Program to Accelerate Domestic Drug Manufacturing

FDA PreCheck; domestic drug manufacturing; pharmaceutical supply chain; API; regulatory streamlining; facility construction; national security; Trump administration

Sanofi axes IGM pact, sparking 80% layoffs at the biotech and facility closures

Sanofi, IGM Biosciences, collaboration termination, biotech layoffs, facility closures, IgM antibodies, immunology, inflammation, oncology

WuXi Biologics Divests Irish Vaccine Facility to Merck for $500 Million Amid Strategic Shift

WuXi Biologics, Merck, vaccine manufacturing facility, Dundalk, Ireland, asset sale, strategic shift, regulatory changes, Biosecure Act